Bsivo enters Samsung Medical Center after Severance and Seoul National University Hospital

Published: 2018-04-06 16:29:00
Updated: 2018-04-06 16:28:21

‘Besivo Tab,’ an Ildong Pharmaceutical’s new chronic hepatitis B treatment, landed in Samsung Medical Center.

‘Besivo’ is increasing a chance to enlarge its market by entering major general hospitals from Severance Hospital, Seoul National University Hospital to Samsung Medical Center.



- Email service daily and homepage access.
  1. $300 per month. ($3,240 per year)
  2. 5 Email holders per each company.
  3. Anual contract base.

Original Korean

Most Read News

Address: 295-1, Chungpa-Ro, Yongsan-Gu, Korea
Phone: 02-3270-0114 | Fax: 02-3270-0129 | Email:

Copyright © Yakup Shinmoon, Inc. All Rights Reserved.